| For: | Baron M, Grise P, Cornu JN. How botulinum toxin in neurogenic detrusor overactivity can reduce upper urinary tract damage? World J Nephrol 2016; 5(2): 195-203 [PMID: 26981445 DOI: 10.5527/wjn.v5.i2.195] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v5/i2/195.htm |
| Number | Citing Articles |
| 1 |
Salvatore Cascio, Stuart O’Toole, Malcolm A. Lewis. Pediatric Surgery. 2022; doi: 10.1007/978-3-642-38482-0_204-1
|
| 2 |
Giulia I. Lane, Sean P. Elliott. Safely Avoiding Surgery in Adult Neurogenic Bladder. Current Bladder Dysfunction Reports 2018; 13(3) doi: 10.1007/s11884-018-0479-y
|
| 3 |
Jacques Corcos, Mikolaj Przydacz. Consultation in Neurourology. 2018; doi: 10.1007/978-3-319-63910-9_12
|
| 4 |
Vasileios I. Sakalis, Rachel Oliver, Peter J. Guy, Melissa C. Davies. Macroplastique and Botox are superior to Macroplastique alone in the management of neurogenic vesicoureteric reflux in spinal cord injury population with presumed healthy bladders. The Journal of Spinal Cord Medicine 2019; 42(4) doi: 10.1080/10790268.2018.1433266
|
| 5 |
M. Baron, M.-A. Perrouin Verbe. Toxina botulínica en el tratamiento de la hiperactividad vesical neurógena y no neurológica. EMC - Urología 2024; 56(1) doi: 10.1016/S1761-3310(23)48767-1
|
| 6 |
Salvatore Cascio, Stuart O’Toole, Malcolm A. Lewis. Pediatric Surgery. 2023; doi: 10.1007/978-3-662-43567-0_204
|